Introduction to Drug Discovery: From Idea to Clinical Candidate

Typical attendees include science-based professionals: biologists, molecular biologists, chemists, preclinical development scientists, informaticians, patent attorneys, project managers and general managers.

The course is a ‘one-stop-shop’ outlining the major scientific tools of drug discovery, namely: Drug Discovery Biology, ADMET/PK/PD, Medicinal Chemistry, Informatics/Virtual technologies and how these contributions are phased over time and integrated to generate a drug suitable for clinical trials.

The focus is on small molecule drugs with comparisons made with biologics. Based on real-world experience and practical realities, attendees travel step-by-step along a typical drug discovery path, namely: Initiating Idea -> Drug Target Protein Selection -> Lead Identification -> Clinical Candidate Nomination. 

Essential related topics include drug discovery technology platforms, drug structural-functional quality attributes and Project management tools, namely Target Product Profile (TPP) use.

Key technology and infrastructure requirements are also covered in the course.

You can see the full course contents here.

One Nucleus Gold Members: £392 + VAT
One Nucleus Silver Members: £476 + VAT
Non-members: £560 + VAT